BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
BECTON DICKINSON & CO
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$190.74−1.01 (-0.53%)
Close on Oct 19, 2026
- Market cap
- $52.48B
- P/E (TTM)
- 57.6
- Dividend yield
- 2.18%
BECTON DICKINSON & CO revenue by segment
By business segment
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Essentials | $1.68B | $1.65B | $1.60B | – | $1.60B | $1.57B | $1.59B | – | – | – | – | – | 33.6% | +4.6% |
| Interventional | $1.41B | $1.36B | $1.33B | $1.37B | $1.33B | $1.26B | $1.26B | $1.26B | $1.24B | $1.29B | $1.19B | $1.20B | 28.4% | +6.5% |
| Connected Care | $1.22B | $1.12B | $1.13B | – | $1.17B | $1.07B | $1.07B | – | – | – | – | – | 24.6% | +5.0% |
| BioPharma Systems | $670.00M | $590.00M | $429.00M | – | $629.00M | $575.00M | $418.00M | – | – | – | – | – | 13.4% | +6.5% |
| Life Sciences | – | – | $766.00M | $1.37B | $1.25B | $1.25B | $836.00M | $1.34B | $1.26B | $1.30B | $1.29B | $1.33B | – | – |
| Medical | – | – | – | $3.15B | $2.93B | $2.76B | $2.62B | $2.84B | $2.56B | $2.45B | $2.23B | $2.55B | – | – |
| Operating income | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Essentials | $617.00M | $574.00M | $569.00M | – | $612.00M | $617.00M | $607.00M | – | – | – | – | – | +0.8% |
| Interventional | $565.00M | $579.00M | $561.00M | $579.00M | $549.00M | $565.00M | $561.00M | – | – | – | – | – | +2.9% |
| Connected Care | $395.00M | $347.00M | $352.00M | – | $417.00M | $353.00M | $336.00M | – | – | – | – | – | -5.3% |
| BioPharma Systems | $259.00M | $225.00M | $140.00M | – | $239.00M | $224.00M | $141.00M | – | – | – | – | – | +8.4% |
| Life Sciences | – | – | $159.00M | – | – | – | $240.00M | – | – | – | – | – | – |
By product or service
By region
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U S [Member] | $3.08B | $2.92B | $3.16B | $4.42B | $2.88B | $2.78B | $3.08B | $3.12B | $2.89B | $2.91B | $2.75B | $2.88B | 61.8% | +6.9% |
| International | $1.90B | $1.80B | $2.09B | $3.88B | $1.84B | $1.70B | $2.09B | $2.32B | $2.10B | $2.14B | $1.96B | $2.21B | 38.2% | +3.1% |
From the segment and revenue-disaggregation notes of Becton Dickinson's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.